SB 922 — Insurance, Health, Accident - As introduced, prohibits an insurance policy that provides benefits for anti-cancer medications that are injected or intravenously administered by a healthcare provider and anti-cancer medications that are patient administered from requiring a higher copayment, deductible, or coinsurance amount for the patient administered anti-cancer medication than for the injected or intravenously administered anti-cancer medication. - Amends TCA Title 56, Chapter 7, Part 23.
Last action — Rec. for pass. if am., ref. to Calendar & Rules Committee
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill died with 110th Regular Session (2017-2018). It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.
Bill Text
We don't have the full text on file for this bill yet.
Read SB 922 on the official Tennessee source →Action History
-
Rec. for pass. if am., ref. to Calendar & Rules Committee
-
Sponsor(s) Added.
-
Action deferred to first calendar of 2018
-
Action deferred in Senate Commerce and Labor Committee to 4/4/2017
-
Placed on Senate Commerce and Labor Committee calendar for 4/4/2017
-
Sponsor(s) Added.
-
Placed on cal. Insurance and Banking Committee for 4/4/2017
-
Action def. in Insurance and Banking Committee to 4/4/2017
-
Sponsor(s) Added.
-
Action deferred in Senate Commerce and Labor Committee to 4/4/2017
-
Placed on Senate Commerce and Labor Committee calendar for 4/3/2017
-
Placed on cal. Insurance and Banking Committee for 3/28/2017
-
Placed on Senate Commerce and Labor Committee calendar for 3/28/2017
-
Action def. in Insurance and Banking Committee to 3/28/2017
-
Rec for pass if am by s/c ref. to Insurance and Banking Committee
-
Placed on cal. Insurance and Banking Committee for 3/21/2017
-
Action Def. in s/c Insurance and Banking Subcommittee to 3/15/2017
-
Placed on s/c cal Insurance and Banking Subcommittee for 3/15/2017
-
Sponsor(s) Added.
-
Placed on s/c cal Insurance and Banking Subcommittee for 3/8/2017
-
Sponsor(s) Added.
-
Sponsor(s) Added.
-
Sponsor(s) Added.
-
P2C, ref. to Insurance and Banking Committee
-
Assigned to s/c Insurance and Banking Subcommittee
-
P1C.
-
Passed on Second Consideration, refer to Senate Commerce and Labor Committee
-
Filed for intro.
-
Intro.
-
Filed for introduction
-
Introduced, Passed on First Consideration
Sponsors
- Ketron · Primary
- William Lamberth · Primary
Sponsorship breakdown
Export CSV (upgrade) →2 sponsors · 0 co-sponsors · 131 not signed on
Sponsors (2)
- Ketron
- Lamberth, William Republican
Co-sponsors (0)
None.
Not signed on (131)
131 members have not signed on to this bill.
Show all 131 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- Who sponsors SB 922?
- SB 922 is sponsored by Ketron and Lamberth, William (Republican).
- What is the current status of SB 922?
- This bill died with 110th Regular Session (2017-2018). It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track SB 922?
- Track SB 922 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 922
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 922
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →